Diabetologie und Stoffwechsel 2025; 20(S 01): S38-S39
DOI: 10.1055/s-0045-1807429
Abstracts | DDG 2025
Poster
Posterwalk 4: Klinische Diabetologie Typ-1 & Typ-2 Diabetes
Langzeit-Wirkung von C-Peptid auf klinische Ergebnisse in der schottischen Type-1-Bioresource-Kohorte
Authors
-
J H Mellor
1
Institute of Genetics and Cancer, University of Edinburgh, Diabetes Informatics &
Epidemiology Unit, Edinburgh, Scotland, United Kingdom
-
LA K Blackbourn
1
Institute of Genetics and Cancer, University of Edinburgh, Diabetes Informatics &
Epidemiology Unit, Edinburgh, Scotland, United Kingdom
-
S J McGurnaghan
1
Institute of Genetics and Cancer, University of Edinburgh, Diabetes Informatics &
Epidemiology Unit, Edinburgh, Scotland, United Kingdom
-
P M McKeigue
1
Institute of Genetics and Cancer, University of Edinburgh, Diabetes Informatics &
Epidemiology Unit, Edinburgh, Scotland, United Kingdom
-
D Müller-Wieland
2
Universitätsklinikum RWTH Aachen, Klinik für Kardiologie, Angiologie und Internistische
Intensivmedizin, Aachen, Germany
-
J Zaccai
3
Sanofi, General Medicines Real World Evidence, Paris, France
-
O Guenther
4
Sanofi, GenMed HEVA, Paris, France
-
N Cui
5
Sanofi, GM Autoimmune Type 1 Diabetes Medical, Paris, France
-
H M Colhoun
1
Institute of Genetics and Cancer, University of Edinburgh, Diabetes Informatics &
Epidemiology Unit, Edinburgh, Scotland, United Kingdom
